For the quarter ending 2026-03-31.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Research and development | 48,547 | 42,519* | 50,476 | 42,760 |
| General and administrative | 11,230 | 15,076* | 11,876 | 12,750 |
| Total operating expenses | 59,777 | 57,595 | 62,352 | 55,510 |
| Loss from operations | -59,777 | -57,595* | -62,352 | -55,510 |
| Interest income | 1,641 | 1,280* | 917 | 1,241 |
| Interest expense | - | 0* | - | - |
| Other income (expense), net | -22 | 3* | -22 | -44 |
| Net loss and comprehensive loss | -58,158 | -56,312* | -61,457 | -54,313 |
| Change in unrealized gains (losses) related to available-for-sale debt securities, net of tax | - | 0 | - | - |
| Total other comprehensive income (loss) | - | 0* | - | - |
| Comprehensive loss | - | -56,312 | - | - |
| Basic EPS | -0.94 | -1.043 | -1.16 | -1.03 |
| Diluted EPS | -0.94 | -1.043 | -1.16 | -1.03 |
| Basic Average Shares | 61,859,485 | 53,986,463 | 52,859,308 | 52,779,162 |
| Diluted Average Shares | 61,859,485 | 53,986,463 | 52,859,308 | 52,779,162 |
Kodiak Sciences Inc. (KOD)
Kodiak Sciences Inc. (KOD)